http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14048735

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 1555
issn 0885-3185
1531-8257
issueIdentifier 8
pageRange 1552-1555
publicationName Movement disorders : official journal of the Movement Disorder Society
startingPage 1552
bibliographicCitation Wong KK, Alty JE, Goy AG, Raghav S, Reutens DC, Kempster PA. A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease. Mov Disord. 2011 Jul;26(8):1552–5. doi: 10.1002/mds.23687. PMID: 21538524.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35e83ed17b3f3740d371d63dcbb2a049
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c149810aaaf17d2ad2561ab39df16ca6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73257c565a7fc804810271d5279496fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5456-8676
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8636-1795
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef9a70139425a791e2dd302ba6188123
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_461c5b306f54f1338c4cea8d6381c624
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5aaec6ed27408df3810d5aedfe5c9af
date 2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/21538524
https://doi.org/10.1002/mds.23687
isPartOf https://portal.issn.org/resource/ISSN/1531-8257
https://portal.issn.org/resource/ISSN/0885-3185
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5937
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A randomized, double‐blind, placebo‐controlled trial of levetiracetam for dyskinesia in Parkinson's disease
discusses http://id.nlm.nih.gov/mesh/M0374035
http://id.nlm.nih.gov/mesh/M0001494
http://id.nlm.nih.gov/mesh/M0016891
http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0012434
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D010889Q000031
http://id.nlm.nih.gov/mesh/D004409Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010300Q000188
http://id.nlm.nih.gov/mesh/D007980Q000009
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000077287
http://id.nlm.nih.gov/mesh/D010889Q000627
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D012720
http://id.nlm.nih.gov/mesh/D018592
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014741
http://id.nlm.nih.gov/mesh/D000978Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10647

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127977224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128093762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128093761

Total number of triples: 54.